Live from the NIH registry
Studies recruiting near Colorado Springs right now
Top 25 of 208 recruiting studies, sorted by proximity — each links to its official registry page
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Penrose-Saint Francis Healthcare — Colorado Springs, Colorado (4.0 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCED
Persistent Corneal Epithelial Defect
Phase 2
Interventional 84 participants sought
Glaukos Investigative Site — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Glaukos Corporation
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
Locally Advanced Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 1,145 participants sought
Research Site — Colorado Springs, Colorado (4.0 mi)
· Sponsor: AstraZeneca
A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
Ulcerative Colitis
Phase 2
Interventional 80 participants sought
Peak Gastroenterology Associates — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Boehringer Ingelheim
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Metastatic Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma
Phase 3
Interventional 1,524 participants sought
UCHealth Memorial Hospital Central — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer
Phase 3
Interventional 600 participants sought
UC Health Oncology Research — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Hoffmann-La Roche
A Phase II Study With a Safety Run-In of the Addition of N-803 to a Chemoimmunotherapy Backbone for the Treatment of Patients With Relapsed or Refractory Neuroblastoma
Neuroblastoma Recurrent
Phase 2
Interventional 54 participants sought
Children's Hospital of Colorado — Colorado Springs, Colorado (4.0 mi)
· Sponsor: St. Jude Children's Research Hospital
Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy
Ig-E Mediated Food Allergy
Phase 2
Interventional 100 participants sought
Asthma & Allergy Associates, P.C. — Colorado Springs, Colorado (4.0 mi)
· Sponsor: RAPT Therapeutics, Inc.
Product Surveillance Registry
Cardiac Rhythm Disorders, Urological Disorders
N/A
Observational 100,000 participants sought
Research site — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Medtronic
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
Phase 3
Interventional 2,150 participants sought
Akero Clinical Study Site — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Akero Therapeutics, Inc
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)
Psychosis Associated With Alzheimer's Disease
Phase 3
Interventional 410 participants sought
Local Institution - 1014 — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Breast Carcinoma, Colorectal Carcinoma
N/A
Observational 2,000 participants sought
Penrose-Saint Francis Healthcare — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Wake Forest University Health Sciences
A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma
Primary Open Angle Glaucoma
Phase 3
Interventional 130 participants sought
Colorado Eye Institute /ID# 277072 — Colorado Springs, Colorado (4.0 mi)
· Sponsor: AbbVie
Efficacy and Safety of 186 mcg of OPN-375 Nasal Spray Twice a Day (BID) in Adolescents With Chronic Rhinosinusitis Without Nasal Polyps
Chronic Rhinosinusitis Without Nasal Polyps
Phase 3
Interventional 84 participants sought
Colorado ENT & Allergy — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Optinose US Inc.
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Arrhythmia, Bradycardia
N/A
Observational 20,000 participants sought
Research site — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Medtronic
JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer
Non-Small Cell Lung Cancer
Phase 3
Interventional 272 participants sought
Penrose Cancer Center — Colorado Springs, Colorado (4.0 mi)
· Sponsor: University of Texas Southwestern Medical Center
Improving Care for Rural Patients With Solid Tumors
Lung Cancer, Head and Neck Cancer
N/A
Interventional 320 participants sought
Memorial Hospital Central — Colorado Springs, Colorado (4.0 mi)
· Sponsor: University of Colorado, Denver
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
Viral Lung Infection and Acute Respiratory Failure
Phase 3
Interventional 3,527 participants sought
Research Site — Colorado Springs, Colorado (4.0 mi)
· Sponsor: AstraZeneca
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Colitis, Ulcerative
Phase 3
Interventional 882 participants sought
Peak Gastroenterology Associates — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Janssen Research & Development, LLC
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 626 participants sought
Local Institution - 007-872-C — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Mirati Therapeutics Inc.
Paclitaxel-Coated Balloon Treatment of Chronic Rhinosinusitis
Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps
N/A
Interventional 300 participants sought
Colorado ENT & Allergy — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Airiver Medical, Inc.
VTP-1000 in Adults With Celiac Disease
Celiac Disease
EARLY/Phase 1
Interventional 45 participants sought
Peak Gastroenterology Associates — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Barinthus Biotherapeutics
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Obesity, Overweight
Phase 3
Interventional 125 participants sought
Children's Hospital Colorado — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Eli Lilly and Company
A Study to Evaluate the Efficacy and Safety of Maintenance Ublituximab Following Induction With Efgartigimod Administration in Participants With Myasthenia Gravis (MG)
Myasthenia Gravis
Phase 2
Interventional 120 participants sought
TG Therapeutics Investigational Trial Site — Colorado Springs, Colorado (4.0 mi)
· Sponsor: TG Therapeutics, Inc.
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Malignant Solid Neoplasm
N/A
Observational 2,062 participants sought
Penrose-Saint Francis Healthcare — Colorado Springs, Colorado (4.0 mi)
· Sponsor: SWOG Cancer Research Network